Progestin intrauterine devices versus copper intrauterine devices for emergency contraception

被引:7
|
作者
Ramanadhan, Shaalini [1 ]
Goldstuck, Norman [2 ]
Henderson, Jillian T. [3 ]
Che, Yan [4 ]
Cleland, Kelly [5 ]
Dodge, Laura E. [6 ]
Edelman, Alison [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
[2] Univ Stellenbosch, Tygerberg Hosp, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Francie van Zyl Dr, ZA-7505 Cape Town, South Africa
[3] Oregon Hlth & Sci Univ, Fertil Regulat Grp, Portland, OR USA
[4] Fudan Univ, NHC Key Lab Reprod Regulat, Shanghai Inst Biomed & Pharmaceut Technol, Shanghai, Peoples R China
[5] Amer Soc Emergency Contracept, Princeton, NJ USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2023年 / 02期
关键词
LEVONORGESTREL; EFFICACY; WOMEN; PREGNANCY; SAFETY; RISK;
D O I
10.1002/14651858.CD013744.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The copper intrauterine device (Cu-IUD) is a highly eEective method of contraception that can also be used for emergency contraception (EC). It is the most eEective form of EC, and is more eEective than other existing oral regimens also used for EC. The Cu-IUD provides the unique benefit of providing ongoing contraception aHer it is inserted for EC; however, uptake of this intervention has been limited. Progestin IUDs are a popular method of long-acting, reversible contraception. If these devices were also found to be eEective for EC, they would provide a critical additional option for women. These IUDs could not only provide EC and ongoing contraception, but additional non-contraceptive benefits, including a reduction in menstrual bleeding, cancer prevention, and pain management. Objectives To examine the safety and eEectiveness of progestin-containing IUDs for emergency contraception, compared with copper-containing IUDs, or compared with dedicated oral hormonal methods. Search methods We considered all randomized controlled trials and non-randomized studies of interventions that compared outcomes for individuals seeking a levonorgestrel IUD (LNG-IUD) for EC to a Cu-IUD or dedicated oral EC method. We considered full-text studies, conference abstracts, and unpublished data. We considered studies irrespective of their publication status and language of publication. Selection criteria We included studies comparing progestin IUDs with copper-containing IUDs, or oral EC methods for emergency contraception. Data collection and analysis We systematically searched nine medical databases, two trials registries, and one gray literature site. We downloaded all titles and abstracts retrieved by electronic searching to a reference management database, and removed duplicates. Three review authors independently screened titles, abstracts, and full-text reports to determine studies eligible for inclusion. We followed standard Cochrane methodology to assess risk of bias, and analyze and interpret the data. We used GRADE methodology to assess the certainty of the evidence.Main results We included only one relevant study (711 women); a randomized, controlled, non-inferiority trial comparing LNG-IUDs to Cu-IUDs for EC, with a one-month follow-up. With one study, the evidence was very uncertain for the diEerence in pregnancy rates, failed insertion rates, expulsion rates, removal rates and the diEerence in the acceptability of the IUDs. There was also uncertain evidence suggesting the Cu-IUD may slightly increase rates of cramping and the LNG-IUD may slightly increase bleeding and spotting days.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer
    Dinger, Juergen
    Bardenheuer, Kristina
    Thai Do Minh
    CONTRACEPTION, 2011, 83 (03) : 211 - 217
  • [42] Intrauterine devices for adolescents: a systematic review
    Deans, Elizabeth I.
    Grimes, David A.
    CONTRACEPTION, 2009, 79 (06) : 418 - 423
  • [43] Use of intrauterine devices in nulliparous women
    Lohr, Patricia A.
    Lyus, Richard
    Prager, Sarah
    CONTRACEPTION, 2017, 95 (06) : 529 - 537
  • [44] Hysteroscopic removal of intrauterine devices in pregnancy
    Sanders, Ari P.
    Sanders, Barry
    FERTILITY AND STERILITY, 2018, 110 (07) : 1408 - 1409
  • [45] The potential association between psychiatric symptoms and the use of levonorgestrel intrauterine devices (LNG-IUDs): A systematic review
    Elsayed, Mohamed
    Dardeer, Khaled T.
    Khehra, Nimrat
    Padda, Inderbir
    Graf, Heiko
    Soliman, Amr
    Makram, Abdelrahman M.
    Zeiss, Rene
    Schonfeldt-Lecuona, Carlos
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2023, 24 (06) : 457 - 475
  • [46] The effect of intrauterine devices on acquisition and clearance of human papillomavirus
    Averbach, Sarah H.
    Ma, Yifei
    Smith-McCune, Karen
    Shiboski, Stephen
    Moscicki, Anna B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (04)
  • [47] Intrauterine Devices and Pelvic Inflammatory Disease Among Adolescents
    Carr, Shannon
    Espey, Eve
    JOURNAL OF ADOLESCENT HEALTH, 2013, 52 (04) : S22 - S28
  • [48] Hormonal intrauterine devices and heat exchange during exercise
    Kirby, Nathalie V.
    Meade, Robert D.
    Richards, Brodie J.
    Notley, Sean R.
    Kenny, Glen P.
    JOURNAL OF PHYSIOLOGY-LONDON, 2024, 602 (05): : 875 - 890
  • [49] Consensus of best practice in intrauterine contraception in France
    Serfaty, David
    Benezech, Jean-Paul
    Heckel, Sergine
    De Reilhac, Pia
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2019, 24 (04) : 305 - 313
  • [50] Safety of hormonal contraception and intrauterine devices among women with depressive and bipolar disorders: a systematic review
    Pagano, H. Pamela
    Zapata, Lauren B.
    Berry-Bibee, Erin N.
    Nanda, Kavita
    Curtis, Kathryn M.
    CONTRACEPTION, 2016, 94 (06) : 641 - 649